The associations between two vital GSTs genetic polymorphisms and lung cancer risk in the Chinese population: Evidence from 71 studies

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Liu, Kui ^a,b   Lin, Xialu ^a   Zhou, Qi ^a   Ma, Ting ^a,b   Han, Liyuan ^a   Mao, Guochuan ^a,c   Chen, Jian ^d   Yue, Xia ^a   Wang, Huiqin ^a   Zhang, Lu ^d   Jin, Guixiu ^a   Jiang, Jianmin ^b   Zhao, Jinshun ^a   Zou, Baobo ^a  

^a NINGBO UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c NINGBO MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; DISEASE ASSOCIATION; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GSTM1 GENE; GSTT1 GENE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; META ANALYSIS; NULL ALLELE; PUBLISHING; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR;

ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84904541379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102372     Document Type: Article

References (125)

1. Tyczynski JE, Bray F, Maxwell Parkin D (2003) Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. The Lancet Oncology 4: 45-55. (Pubitemid 36124190)
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: A Cancer Journal for Clinicians 61: 69-90.
3. Zhao J, Kim JE, Reed E, Li QQ (2005) Molecular mechanism of antitumor activity of taxanes in lung cancer (Review). International Journal of Oncology 27: 247.
4. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 62: 10-29.
5. Lam W, White N, Chan-Yeung M (2004) Lung cancer epidemiology and risk factors in Asia and Africa State of the Art. The International Journal of Tuberculosis and Lung Disease 8: 1045-1057. (Pubitemid 39201249)
6. American Cancer Society (2012) American Cancer Society: Cancer Facts & Figures 2012. Atlanta: American Cancer Society.
7. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500. (Pubitemid 38720929)
8. Ramalingam SS, Owonikoko TK, Khuri FR (2011) Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin 61: 91-112.
9. Tucker ZC, Laguna BA, Moon E, Singhal S (2012) Adjuvant immunotherapy for non-small cell lung cancer. Cancer Treat Rev 38: 650-661.
10. Kimura H, Yamaguchi Y (1995) Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer. Lung Cancer 13: 31-44.
11. Ebina T, Fujimiya Y (2008) Cell transfer regimens in patients with highly advanced surgically unresectable non-small cell lung cancer: Significantly improved overall survival in patients with lower levels of serum immunosuppressive acidic protein. Lung Cancer 60: 246-251. (Pubitemid 351609139)
12. Li R, Wang C, Liu L, Du C, Cao S, et al. (2012) Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study. Cancer Immunology, Immunotherapy 61: 2125-2133.
13. Iwai K, Soejima K, Kudoh S, Umezato Y, Kaneko T, et al. (2012) Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort study. Cancer Immunology, Immunotherapy 61: 1781-1790.
14. Shi SB, Ma TH, Li CH, Tang XY (2011) Effect of maintenance therapy with dendritic cells: cytokine-induced killer cells in patients with advanced non-small cell lung cancer. 98(3): 314-319.
15. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, et al. (1999) Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. Journal of the National Cancer Institute 91: 675-690. (Pubitemid 29234561)
16. Sasco A, Secretan M, Straif K (2004) Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45: S3-S9. (Pubitemid 39488165)
17. Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute 91: 1194-1210.
18. Loft S, Poulsen HE (1996) Cancer risk and oxidative DNA damage in man. J Mol Med (Berl) 74: 297-312. (Pubitemid 26195901)
19. Jaruga P, Zastawny TH, Skokowski J, Dizdaroglu M, Olinski R (1994) Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 341: 59-64. (Pubitemid 24089190)
20. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, et al. (2003) DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 95: 1312-1319. (Pubitemid 37160864)
21. Gackowski D, Speina E, Zielinska M, Kowalewski J, Rozalski R, et al. (2003) Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Research 63: 4899-4902. (Pubitemid 37022624)
22. Liu K, Zhang L, Lin X, Chen L, Shi H, et al. (2013) Association of GST Genetic Polymorphisms with the Susceptibility to Hepatocellular Carcinoma (HCC) in Chinese Population Evaluated by an Updated Systematic Meta-Analysis. PloS One 8: e57043.
23. de Mello RA, Ferreira M, Pires FS, Costa S, Luis M, et al. (2013) The role of genetic polymorphisms at the chromosomes 5p15, 6p12, 6p21 and 15q25 in non-small-cell lung cancer prognosis: a Portuguese prospective study. BioMed Central Ltd (Suppl 2):P57.
24. Hu L, Zhuo W, He YJ, Zhou HH, Fan L (2012) Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy. Pharmacogenetics and Genomics 22: 812-819.
25. Nebert DW, McKinnon RA, Puga A (1996) Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15: 273-280. (Pubitemid 26124084)
26. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR (1995) Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25: 27-65.
27. Udomsinprasert R, Pongjaroenkit S, Wongsantichon J, Oakley AJ, Prapanthadara LA, et al. (2005) Identification, characterization and structure of a new Delta class glutathione transferase isoenzyme. Biochem J 388: 763-771. (Pubitemid 40941562)
28. Frova C (2006) Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng 23: 149-169.
29. Fryer AA, Zhao L, Alldersea J, Pearson W, Strange R (1993) Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A, B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem J 295: 313-315. (Pubitemid 23298343)
30. Pemble S, Schroeder K, Spencer S, Meyer D, Hallier E, et al. (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300: 271-276. (Pubitemid 24151046)
31. Dejong JL, Mohandas T, Tu CPD (1991) The human Hb (mu) class glutathioneS-transferases are encoded by a dispersed gene family. Biochemical and Biophysical Research Communications 180: 15-22.
32. Seidegård J, Vorachek WR, Pero RW, Pearson WR (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proceedings of the National Academy of Sciences 85: 7293-7297.
33. Strange RC, Spiteri MA, Ramachandran S, Fryer AA (2001) Glutathione S-transferase family of enzymes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 482: 21-26.
34. Bolt H, Thier R (2006) Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Current Drug Metabolism 7: 613-628. (Pubitemid 44226589)
35. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J (2006) Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 3: e91.
36. Shukla R, Tilak A, Kumar C, Kant S, Kumar A, et al. (2013) Associations of CYP1A1, GSTM1 and GSTT1 Polymorphisms with Lung Cancer Susceptibility in a Northern Indian Population. Asian Pac J Cancer Prev 14: 3345-3349.
37. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z (2008) CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 59: 155-163. (Pubitemid 351173406)
38. Li C, Yin Z, Zhou B (2011) CYP1A1 gene and GSTM1 gene polymorphism and the combined effects and risk of lung cancer: a meta-analysis. Zhongguo Fei Ai Za Zhi 14: 660-668.
39. Yang X, Qiu MT, Hu JW, Wang XX, Jiang F, et al. (2013) GSTT1 null genotype contributes to lung cancer risk in asian populations: a meta-analysis of 23 studies. PLoS One 8: e62181.
40. Wang Y, Yang H, Li L, Wang H (2010) Glutathione S-transferase T1 gene deletion polymorphism and lung cancer risk in Chinese population: a meta-analysis. Cancer Epidemiol 34: 593-597.
41. Zhou HF, Feng X, Zheng BS, Qian J, He W (2013) A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects. Mol Biol Rep 40: 5713-5721.
42. Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara M, et al. (2008) CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 17: 1120-1126.
43. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167: 759-774. (Pubitemid 351451750)
44. Vlastos F, Hillas G, Anagnostopoulos N, Vignaud JM, Martinet N, et al. (2013) Polymorphisms of GSTs in Lung Adenocarcinoma Patients Followed in the Context of a Biobank. Journal of Cancer Therapy 04: 24-28.
45. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, et al. (2006) Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164: 1027-1042. (Pubitemid 44851738)
46. Hosgood HD 3rd, Berndt SI, Lan Q (2007) GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. Mutat Res 636: 134-143. (Pubitemid 350123118)
47. Hardy GH (1908) Mendelian proportions in a mixed population. Science 28: 49-50.
48. Schaid DJ, Jacobsen SJ (1999) Blased Tests of Association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. American Journal of Epidemiology 149: 706-711. (Pubitemid 29180778)
49. Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, et al. (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. The Lancet Oncology 10: 772-784.
50. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. (Pubitemid 34746062)
51. Hedges LV, Vevea JL (1998) Fixed-and random-effects models in meta-analysis. Psychological methods 3: 486.
52. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
53. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
54. Liu DZ, Wang F, Wang QS, Guo XT, Xu H, et al. (2012) Association of Glutathione S-Transferase M1 Polymorphisms and Lung Cancer Risk in a Chinese Population. Clinica Chimica Acta 414: 188-190.
55. Wang N, Wu YJ, Zhou XL, Wu YM (2012) Association Between Genetic Polymorphism of Metabolizing Enzymes and DNA Repairing Enzymes and the Susceptibility of Lung Cancer in Henan Population. Journal of Hygiene Research 41: 251-256.
56. Li WY, Yue WT, Zhang LN, Zhao XT, Ma L, et al. (2012) Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients. Lung 190: 91-98.
57. Chen CM, Jin YT, Xu HY, Zhang CY, Zhang H, et al. (2012) Effects of Cyp1A1 and GSTM1 Gene Polymorphisms and Bpde-DNA Adducts On Lung Cancer. Chinese Journal of Medical Genetics 29: 23-27.
58. Yao ZG, Yong E, Wang HY (2012) The Interacted Effects Between Glutathione S-Transferase Gene Polymorphism and Smoking in Lung Cancer. Chinese Journal of Medical Guide 14: 185-186,188.
59. Liu JN, Zhou CC, Piao HM, An CS (2012) Relationship Between GSTT1 Genetic Polymorphism, Smoking and Lung Cancer Susceptibility. Basic &Clinical Medicine 32: 1194-1197.
60. Han RL, Bai TY, Chang FH, Lv XL, Li C, et al. (2012) GSTM1 Gene Polymorphism and Lung Cancer Susceptibility in Man Population. Central South Pharmacy 10: 1-4.
61. Jin YT, Zhang CY, Xu HY, Xue SL, Wang YS, et al. (2011) Combined Effects of Serum Trace Metals and Polymorphisms of Cyp1A1 Or GSTM1 On Non-Small Cell Lung Cancer: A Hospital Based Case-Control Study in China. Cancer Epidemiology 35: 182-187.
62. Ai C (2011) Discuss the Influences of GSTM1 Gene Polymorphism of Lung Cancer. Contemporary Medicine 17: 50.
63. Zhang JQ, Long XY, Xiong GS, Fang LZ, Zhao ZH, et al. (2011) The Relationship Between Glutathione S-Transferase M1 and Susceptibility to Xuanwe's Lung Cancer. Journal of Kunming Medical University 32: 56-58,67.
64. Du GB, Ma DY, Tan BX, Liu M, Zhao YL, et al. (2011) Relationship Between Genetic Polymorphism of GSTM1 Gene and Susceptibility to Lung Cancer in the Population of Northern Sichuan of China. Chinese Clinical Oncology 16: 602-605.
65. Li Y, Chen J, Gao YX (2011) Influence of Smoking and the Polymorphisms of Cyp1A1 and GSTM1 On the Susceptibility of Lung Cancer. Journal of Chinese Practical Diagnosis and Therapy 25: 140-143.
66. Bai TY, Chang FH, Wang MJ, Wang G, Zhang S (2011) Relationship Between GSTT1 and Cyp1A1 Genetic Polymorphisms and Lung Cancer Susceptibility. Chinese Journal of Public Health 27: 723-725.
67. Jin YT, Xu HY, Zhang CY, Kong YM, Hou Y, et al. (2010) Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes On Non Small Cell Lung Cancer: A Hospital-Based Case-Control Study in China. BMC Cancer 10: 422.
68. Zheng DJ, Hua F, Mei CR, Wan HT, Zhou QH (2010) Association Between GSTM1 Genetic Polymorphism and Lung Cancer Risk by Sybr Green I Real-Time Pcr Assay. Chinese Journal of Lung Cancer 13: 506-510.
69. Zhu XX, Hu CP, Gu QH (2010) Cyp1 a1 Polymorphisms, Lack of Glutathione S-Transferase M1 (GSTM1), Cooking Oil Fumes and Lung Cancer Risk in Non-Smoking Women. Chinese Journal of Tuberculosis and Respiratory Diseases 33: 817-822.
70. Fan J, Gan LG, Liang KC, Liang XM (2010) Relationship of GSTM1 and GSTT1 Genetic Polymorphisms with Lung Cancer Susceptibility in Guangxi Zhuang Population. Journal of Oncology 16: 922-925.
71. Chang FH, Wang MJ, Qi J, Yin Q, Fan L, et al. (2009) Genetic Polymorphism of T6235C Mutation in 3'Non-Coding Region of Cyp1A1 and GSTM1 Genes and Lung Cancer Susceptibility in the Mongolian Population. Academic Journal of Xi'an Jiaotong University 21:225-229.
72. Chen H, Yu ZC, Jin YT, Xue SL, Kong YM, et al. (2008) Influence of Genetic Polymorphism of Cyp1A1 Gene and GSTMl Gene On Lung Cancer. Shandong Medical Journal 48: 20-22.
73. Liu Q, Liu J, Song B, Wang ZH (2008) Relationship Between Susceptibility to Lung Cancer and Genetic Polymorphism in Cyp1A1 and GSTM1. Shandong Medical Journal 48: 32-34.
74. Qi XS, Lv HM, Xia Y, Shang B, Sun QF, et al. (2008) A Primary Case-Control Study On the Relationship Between Genetic Polymorphisms of GSTT1 and Lung Cancer Susceptibility to the People Living in High Radon-Exposed Area. China Occupational Medicine 35: 361-363,367.
75. Xia Y, Sun QF, Shang B, Lv HM, Feng SZ, et al. (2008) Polymorphisms of the Cytochrome P450 and Glutathione S-Transferase Genes Associated with Lung Cancer Susceptibility for the Residents in High Radon-Exposed Area. Chinese Journal of Radiological Medicine and Protection 28: 327-332.
76. Gu YF, Zhang ZD, Zhang SC, Zheng SH, Jia HY, et al. (2007) Combined Effects of Genetic Polymorphisms in Cytochrome P450S and GSTM1 On Lung Cancer Susceptibility. National Medical Journal of China 87: 3064-3068.
77. Wang YS, Jin YT, Xue SL, Yu ZC, Xu YC, et al. (2007) Study On the Methylation of P16 Gene and Genetic Polymorphism of GSTM1 Gene Related with Susceptibility to Non-Small Cell Lung Cancer. Modern Preventive Medicine 34: 1207-1209,1212.
78. Lei FM, Li SF, Zhou WD, Luo WH, He JY, et al. (2007) A Case-Control Study of the Impact of Glutathione S-Transferase M1 Polymorphism On the Risk of Lung Cancer. Modern Preventive Medicine 34: 724-726.
79. Chang FH, Hu TM, Wang G (2006) Relationship Between Cyp1A1 and GSTM1 Genetic Polymorphisms and Lung Cancer Susceptibility in Population of Inner Mongolia. Chinese Journal of Lung Cancer 9: 413-417.
80. Chen HC, Cao YF, Hu WX, Liu XF, Liu QX, et al. (2006) Genetic Polymorphisms of Phase Ii Metabolic Enzymes and Lung Cancer Susceptibility in a Population of Central South China. Disease Markers 22: 141-152.
81. Li Y, Chen J, He X, Gao SS, Fan ZM, et al. (2006) Cyp1A1 and GSTM1 Polymorphisms and Susceptibility to Lung Cancer. Journal of Zhengzhou Univeristy(Medical Sciences) 41: 1061-1064.
82. Yao W, Wang N, Wu YJ, Wu YM (2006) Relationship Between Deletion of GSTM1, GSTT1 Genes and Susceptibility to Lung Cancer. Chinese Journal of Public Health 22: 1070-1072.
83. Qian BY, Han HW, Gu F, He M, Li HX, et al. (2006) Case-Control Study Genetic Polymorphism in Cyp1A1 and GSTM1 and Smoking and Susceptibility to Lung Cancer. Chinese Journal of Clinical Oncology 33: 500-502. (Pubitemid 43886251)
84. Wang Q, Lu QL, Zhen HN, Bao M, Zhang HJ (2006) Relationship Between Cyp2C9 and Gst M1 Genetic Polymorphism and Lung Cancer Susceptibility. Cancer Research On Prevention and Treatment 33: 8-10.
85. He DX, Chan Y (2006) The Relationship of GSTT1 Polymorphism and Chromosome 15 Aberration in Lung Cancer Patients. Cancer Research On Prevention and Treatment 33: 308-310,383.
86. Chan EC, Lam SY, Fu KH, Kwong YL (2005) Polymorphisms of the GSTM1, Gstp1, Mpo, Xrcc1, and Nqo1 Genes in Chinese Patients with Non-Small Cell Lung Cancers: Relationship with Aberrant Promoter Methylation of the Cdkn2a and Rarb Genes. Cancer Genetics and Cytogenetics 162: 10-20. (Pubitemid 41278465)
87. Yuan TZ, Zhou QH, Zhu W, Guo ZL, Li DY, et al. (2005) Relationship Between Genetic Polymorphism of GSTT1 Gene and Inherent Susceptibility to Lung Cancer in Han Population in Sichuan, China. Chinese Journal of Lung Cancer 8: 107-111. (Pubitemid 40570623)
88. Li DR, Zhou QH, Yuan TZ, Guo ZL, Zhu W, et al. (2005) Study On the Association Between Genetic Polymorphism of Cyp2E1, GSTM1 and Susceptibility of Lung Cancer. Chinese Journal of Lung Cancer 8: 14-19. (Pubitemid 40292667)
89. Ye WY, Chen SD, Chen Q (2005) Interaction Between Serum Selenium Level and Polymorphism of GSTM1 in Lung Cancer. Acta Nutrimenta Sinica 27: 17-20.
90. Chou YC, Wu MS, Wu CC, Yang T, Chu CM, et al. (2005) Total Urinary Isothiocyanates, Glutathione S-Transferase M1 Genotypes, and Lung Cancer Risk: A Preliminary Nested Case-Control Study in Taiwan. J Med Sci 25: 021-026.
91. Liang GY, Pu YP, Yin LH (2004) Studies of the Genes Related to Lung Cancer Susceptibility in Nanjing Han Population, China. Hereditas(Beijing) 26: 584-588.
92. Yang XR, Wacholder S, Xu Z, Dean M, Clark V, et al. (2004) Cyp1A1 and GSTM1 Polymorphisms in Relation to Lung Cancer Risk in Chinese Women. Cancer Letters 214: 197-204. (Pubitemid 39207981)
93. ChanYeung M, TanUn KC, Ip MSM, Tsang KWT, Ho SP, et al. (2004) Lung Cancer Susceptibility and Polymorphisms of Glutathione-S-Transferase Genes in Hong Kong. Lung Cancer 45: 155-160.
94. Lan Q, He XZ (2004) Molecular Epidemiological Studies On the Relationship Between Indoor Coal Burning and Lung Cancer in Xuan Wei, China. Toxicology 198: 301-305. (Pubitemid 38609042)
95. Gu YF, Zhang SC, Lai BT, Wang H, Zhan XP (2004) Relationship Between Genetic Polymorphism of Metabolizing Enzymes and Lung Cancer Susceptibility. Chinese Journal of Lung Cancer 7: 112-117. (Pubitemid 38525036)
96. Dong CT, Yang Q, Wang MZ, Dong QN (2004) A Study On the Relationship Between Polymorphism of Cyp1A1, Lack of GSTM1 and Susceptibility to Lung Cancer. Journal of Environmental and Occupational Medicine 21: 440-442.
97. Luo CL, Qing C, Cao WF, Chen SD (2004) Combined Analysis of Polymorphisms of GSTM1 and Mutations of P53 Gene in the Patients with Lung Cancer. Chinese Journal of Clinical Oncology 31: 1218-1220,1224.
98. Cao YF, Chen HC, Liu XF, Liu QX, Zhang J, et al. (2004) Study On the Relationship Between the Genetic Polymorphisms of GSTM1 and GSTT1 Genes and Lung Cancer Susceptibility in the Population of Hunan Province of China. Life Science Research 8: 126-132.
99. Chen SD, Zeng M, Li ZB, Wang BG, Chen MX, et al. (2004) A Case Control Study On the Impact of Cyp2E1 and Gst-M1 Polymorphisms On the Risk of Lung Cancer. Tumor 24: 99-103.
100. Huang XH, Chen SD, Wang BG, Zhou WP, Cai XL (2004) Study On the Impact of GSTM1 Polymorphisms On the Risk of Histologic Types of Lung Cancer: A Case-Control Study. Journal of Public Health and Preventive Medicine 15: 24-26.
101. Ye WY, Chen Q, Chen SD (2004) Study On Relationship Between GSTM1 Polymorphism, Diet Factors and Lung Cancer. Chinese Journal of Public Health 20: 1120-1121.
102. Wang JW, Deng YF, Cheng JL, Ding JM, Tokudome S (2003) Gst Genetic Polymorphisms and Lung Adenocarcinoma Susceptibility in a Chinese Population. Cancer Lett 201: 185-193.
103. Wang JW, Deng YF, Li L, Kuriki K, Ding JM, et al. (2003) Association of GSTM1, Cyp1A1 and Cyp2E1 Genetic Polymorphisms with Susceptibility to Lung Adenocarcinoma: A Case-Control Study in Chinese Population. Cancer Sci 94: 448-452. (Pubitemid 36790478)
104. Chen LJ, Sun HL, Xu YQ (2003) Study On the Allele Frequency of GSTM1 Gene in Normal Han Population in Wan-Nan Area and the Relationship Between GSTM1 Genotype and the Risk of Lung Cancer. Acta Academiae Medicinae Wannan 22: 13-16.
105. Li WY, Lai BT, Zhan XP (2003) Polymorphism of Metabolic Enzyme Genes Associated with Lung Cancer Susceptibility. Tuberculosis and Thoracic Tumor 4:280-286.
106. Lu WF, Xing DY, Qi J, Tan W, Miao XP, et al. (2002) Genetic Polymorphism in Myeloperoxidase but Not GSTM1 is Associated with Risk of Lung Squamous Cell Carcinoma in a Chinese Population. Int J Cancer 102: 275-279. (Pubitemid 35222299)
107. Qiao GB, Wu YL, Zeng WS, Jiang RC, Wang SY, et al. (2002) Case-Control Study of GSTM1 Gene Deletion and Non-Small Cell Lung Cancers. Academic Journal of Sun Yat-Sen University of Medical Sciences 23: 25-27.
108. Zhang LZ, Wang X, Hao XZ, Shi YX, Liu ZH (2002) Relationship Between Susceptibility to Lung Cancer and Genetic Polymorphism in P4501a1, GSTM1. Chinese Journal of Clinical Oncology 29: 536-540.
109. Shi Y, Zhou XW, Zhou YK, Ren S (2002) Analysis of Cyp2E1, GSTM1 Genetic Poi Ymorphismsin Relation to Human Lung Cancer and Esophageal Carcinoma. Journal of Huazhong University of Science and Technology(-Health Sciences) 31: 14-17.
110. Zhang JK, Hu YL, Hu CF, Wang SY (2002) Relationship Between Genetic Polymorphisms of GSTM1 as Well as GSTT1 and Lung Cancer. Chinese Journal of Pathophysiology 18: 352-355.
111. Zhang JK, Hu YL, Hu CF, Wang SY (2002) Study On Genetic Polymorphisms of GSTM1 and GSTT1 Related with Inherent Susceptibility to Lung Cancer in Women. China Public Health 18: 273-275.
112. Xin Y, Wang X, Wang XY, Liang ZQ (2002) A Study of Genetic Polymorphism of GSTM1 Gene in Normal Population and Lung Cancer Population in Yunnan. Journal of Yunan Normal University (Natural Sciences Edition) 22: 52-54.
113. Cheng YW, Hsieh LL, Lin PP, Chen CP, Chen CY, et al. (2001) Gender Difference in Dna Adduct Levels Among Nonsmoking Lung Cancer Patients. Environ Mol Mutagen 37: 304-310.
114. Chen SQ, Xue KX, Xu L, Ma GJ, Wu JZ (2001) Polymorphisms of the Cyp1A1 and GSTM1 Genes in Relation to Individual Susceptibility to Lung Carcinoma in Chinese Population. Mutat Res 458: 41-47. (Pubitemid 34246235)
115. London SJ, Yuan JM, Chung FL, Gao YT, Coetzee GA, et al. (2000) Isothiocyanates, Glutathione S-Transferase M1 and T1 Polymorphisms, and Lung-Cancer Risk: A Prospective Study of Men in Shanghai, China. Lancet 356: 724-729. (Pubitemid 30663242)
116. Cheng YW, Chen CY, Lin P, Huang KH, Lin TS, et al. (2000) DNA Adduct Level in Lung Tissue May Act as a Risk Biomarker of Lung Cancer. Eur J Cancer 36: 1381-1388.
117. Lan Q, He XZ, Costa D, Tian LW, Lu XB, et al. (1999) Glutathione S-Transferase GSTM1 and GSTT1 Genotypes and Susceptibility to Lung Cancer. Journal of Hygiene Research 28: 9-11.
118. Gao Y, Zhang Q (1999) Polymorphisms of the GSTM1 and Cyp2D6 Genes Associated with Susceptibility to Lung Cancer in Chinese. Mutat Res 444: 441-449. (Pubitemid 29469488)
119. Chen SQ, Xu L, Ma GJ, Wu JZ, Xue KX (1999) Identification of Genetic Polymorphism of Cyp1A1 and GSTM1 in Lung Cancer Patients by Using Allele - Specific PCR and Multiplex Differential Pcr. Carcinogenesis,Teratogenesis & Mutagenesis 11:119-121.
120. Gao JR, Zhang Q (1998) Study On the Relationship Between GSTM1 Polymorphism and Lung Cancer Susceptibility. Carcinogenesis, Teratogenesis & Mutagenesis 10: 149-151.
121. Qu YH, Shi YB, Zhong LJ, Sun L, Sun XW, et al. (1998) The Genotypes of Cytochrome P450 1a1 and GSTM1 in Nonsmoking Female Lung Cancer. Tumor 18:80-82.
122. Sun GF, Shimojo N, Pi J, Lee S, Kumagai Y (1997) Gene Deficiency of Glutathione S-Transferase Mu Isoform Associated with Susceptibility to Lung Cancer in a Chinese Population. Cancer Lett 113: 169-172. (Pubitemid 27113245)
123. Ge H, Lam WK, Lee J, Wong MP, Yew WW, et al. (1996) Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients. Lung Cancer 15: 355-366. (Pubitemid 26399514)
124. Sun GF, Pi JB, Zheng QM, Zheng QM, Harada B, et al. (1995) Study on relationship between Glutathione S-transferase m gene deficiency and Lung cancer. Chinese Journal Tuberculosis and Respiratory Diseases 18:167-169.
125. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP (2006) Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 163: 300-309. (Pubitemid 43238423)